Company: JACS-RI
Filing Date: 2025-03-18
Form Type: 10-K
Source: 0001013762-25-000620
Chunk: 62

Company: Jackson Acquisition Co II
Filing Date: 2025-03-18
Form: 10-K
Item: Item 1
Chunk 62
---
 applied generally towards consummating a business combination
and working capital.

Since our IPO, our sole
business activity has been identifying and evaluating suitable acquisition transaction candidates. We presently have no revenue and have
had losses since inception from incurring formation and operating costs. We have relied upon the sale of our securities and loans from
the Sponsor and other parties to fund our operations.

The Class A Ordinary Shares
and Rights are trading on the New York Stock Exchange (“NYSE”) under the symbols “JACS” and “JACS.R,”
respectively. Public Units not separated will continue to trade on the NYSE under the symbol “JACS.U”. Holders of Public Units
will need to have their brokers contact the Company’s transfer agent, Continental Stock Transfer & Trust Company, in order to
separate the holders’ Public Units into Class A Ordinary Shares and Rights.

Business Strategy and Competitive Strengths

Our goal is to complete a business
combination with a company that is fundamentally healthy and then to work with that company to access the capital markets, attract experienced
management talent, and execute a proprietary value-creation business plan, designed to help the company to grow into the next phase of
its life cycle. We plan to focus on identifying acquisition candidates to leverage our management’s deep experience in the integration
and coordination of healthcare services, as well as to capitalize on the current healthcare trends and valuation dislocation. We plan
to employ a fundamental, value-oriented acquisition framework that seeks a target with the potential for significant equity value creation
coupled with strong downside protection from dependable cash flows and a durable business franchise. Our management team along with our
board of directors have experience in:

●operating companies in the public and private markets, defining
corporate strategy, and identifying, mentoring and recruiting leading talent, and identifying and executing on operational improvements
that drive value;

●growing companies, both organically and through strategic transactions,
expanding product portfolios and broadening geographic footprints;

1

●building strong sales networks to drive organic growth across
market segments, targeting a wide range of payor and referral sources, with a focus on compliance and customer service across all parties
in the care delivery and reimbursement chain;

●strategically investing in leading private and public healthcare
and other companies to help accelerate growth and maturation;

●sourcing, structuring, acquiring and selling businesses;

●accessing public and private capital markets to optimize capital
structure, including financing businesses and helping companies transition ownership structures; and

●